Cough in idiopathic pulmonary fibrosis
- PMID: 27581827
- PMCID: PMC9487209
- DOI: 10.1183/16000617.0090-2015
Cough in idiopathic pulmonary fibrosis
Abstract
Many patients with idiopathic pulmonary fibrosis (IPF) complain of chronic refractory cough. Chronic cough is a distressing and disabling symptom with a major impact on quality of life. During recent years, progress has been made in gaining insight into the pathogenesis of cough in IPF, which is most probably "multifactorial" and influenced by mechanical, biochemical and neurosensory changes, with an important role for comorbidities as well. Clinical trials of cough treatment in IPF are emerging, and cough is increasingly included as a secondary end-point in trials assessing new compounds for IPF. It is important that such studies include adequate end-points to assess cough both objectively and subjectively. This article summarises the latest insights into chronic cough in IPF. It describes the different theories regarding the pathophysiology of cough, reviews the different methods to assess cough and deals with recent and future developments in the treatment of cough in IPF.
Copyright ©ERS 2016.
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside the online version of this article at
Figures
References
-
- Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). The Voice of the Patient: A series of reports from the U.S. Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative. www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM44... Date last updated: March, 2015.
-
- King TE Jr, Bradford WZ, Castro-Bernardini S, et al. . A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083–2092. - PubMed
-
- Richeldi L, du Bois RM, Raghu G, et al. . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071–2082. - PubMed
-
- Ryerson CJ, Abbritti M, Ley B, et al. . Cough predicts prognosis in idiopathic pulmonary fibrosis. Respirology 2011; 16: 969–975. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical